ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

CVM Cel Sci Corporation New

1,31
0,04 (3,15%)
06 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Cel Sci Corporation New CVM AMEX Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,04 3,15% 1,31 18:16:43
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,31 1,25 1,32 1,28 1,27
mais cotações »

Notícias Recentes

Data Hora Fonte Título
06/06/202408:00BWDr. Giovanni Selvaggi, Who Has Brought Several Oncology..
16/05/202410:00BWCEL-SCI Corporation Reports Second Quarter Fiscal 2024..
08/05/202410:00BWCEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of..
23/04/202410:00BWCEL-SCI Appoints Mario Gobbo to Its Board of Directors
19/03/202410:00BWCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to..
06/03/202410:45BWCEL-SCI Corporation Issues Letter to Shareholders
15/02/202410:00BWCEL-SCI Corporation Reports First Quarter Fiscal 2024..
13/02/202414:00BWCEL-SCI Announces Closing of $7.75 Million Public Offering..
09/02/202410:30BWCEL-SCI Announces Pricing of $7.75 Million Public Offering..
06/02/202411:00BWCEL-SCI Completes Commissioning of Its Multikine..
31/01/202411:00BWEuropean Medicines Agency Grants CEL-SCI a Waiver of Strict..
22/12/202310:00BWCEL-SCI Reports Fiscal 2023 Financial Results and Clinical &..
04/12/202310:30BWUK’S National Institute for Health and Care Excellence..
20/11/202318:15BWCEL-SCI Announces Closing of $5 Million Public Offering of..
16/11/202310:30BWCEL-SCI Announces Pricing of $5 Million Offering of Common..
30/10/202310:20BWCEL-SCI Issues Letter to Shareholders
24/10/202309:00BWCEL-SCI Releases Video Detailing Recent Phase 3 Findings &..
23/10/202310:15BW5-Year Head & Neck Cancer Survival Increased From 45% to 73%..
19/10/202309:00BWCEL-SCI Readies Its Multikine Manufacturing Facility for..
05/10/202309:45BWCEL-SCI Files Request With the UK’s MHRA Regarding Path to..
26/09/202310:00BWCEL-SCI Submits Scientific Advice Filing to European..
11/08/202309:00BWCEL-SCI Corporation Reports Third Quarter Fiscal 2023..
20/07/202312:36BWCEL-SCI Announces Closing of Public Offering
17/07/202322:23BWCEL-SCI Announces Pricing of Public Offering
17/07/202317:05BWCEL-SCI Announces Proposed Public Offering of Common Stock
14/07/202310:15BWCEL-SCI Concludes Positive Meeting With U.S. FDA Concerning..
11/07/202309:45BWCEL-SCI Reports Phase 3 Tumor PD-L1 Biomarker Data..
22/06/202311:19BWCEL-SCI to Present Novel Data at AHNS 11th International..